Epstein Secrets

temporary reversal of the upward trend." However, according to Bloomberg, "A model based on 40 forecasts tracked by the University of Massachusetts Amherst's Reich Lab indicates that, in the next month or so, the seven-day average deaths will probably near the record pace of about 2,200 a day from the p

g, too, ready to use that desperation to their advantage, federal investigators say." The AP adds, "Homeland Security investigators are working with Pfizer, Modema and dozens of other drug companies racing to complete and distribute the vaccine and treatments for the virus. The goal: to prepare for the

Surge After Holiday; Biden Names Economic Team; Trump Contests Election; Assassination Of Iranian Scientist. CBS: COVID Cases Surge After Holiday; Pfizer, Modena Seek Vaccine Approval; Trump Contests Election; Biden Names Economic Team; Assassination Of Iranian Scientist. NBC: COVID Cases Surge After

y deaths has been "predicted in the range of 1,643 to 1,886 through Dec. 26, according to a four-week forecast from the University of Massachusetts Amherst's Reich Lab." On the CBS Evening News <https://playvideo.bulletinintelligence.corn/c943fe36666745a4a80e9590602debf6? pubid=fbi> (12/7, story 2, 2:2

those in December and hold back the other half to give the same people their second dose of the two-shot regimen," but former FDA commissioner and Pfizer board member Scott Gottlieb "says that's a bad idea. Instead, Gottlieb says he would give out 35 million doses now, and presume the second doses wil

charges stemming from threats to hang and kill members of Congress if they didn't 'get behind' former President Donald Trump." Ryder Winegar, 34, of Amherst, New Hampshire, "entered guilty pleas Friday to six counts of threatening members of Congress and one count of transmitting threatening communicati

d Monday." Defense Secretary Austin "said in a memo to the staff Monday that he would seek to speed up a vaccine mandate if the F.D.A. approved the Pfizer-BioNTech vaccine before the middle of September, which the agency aims to do." The Wall Street Journal (8/9, Al, Siddiqui, Subscription Publication,

ontracts and right of first refusal in phase III clinical trials (with appropriate patient populations) from Novartis, Smith Kline Beecham, Amgen and Pfizer and other pharmaceutical and biotech companies. e Grew research revenue by increasing clinical trials by 40% and patient enrollment by over 320% ann

assigned nursing staff, maintained detailed written records and electronic medical records for all patients. EDUCATION University of Massachusetts, Amherst, Massachusetts. M.S. Exercise Physiology, Cum Laude, 1987. University of Florida, Gainesville, Florida. B.S. Nursing, Cum Laude, 1979. HOUSE_OVERSIG